PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'NexVac Research Center, Comprehensive AIDS Research Center, Center for Infectious Disease Research, Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University, Beijing, China.\', \'Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.\', \'Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.\', \'The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, Beijing, China.\', \'School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China.\', \'Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People\'s Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China.\', \'Infectious Disease Translation Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.\', \'Beijing Youan Hospital, Capital Medical University, Beijing, China.\', \'Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.\', \'Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.766821
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34966387
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all